Medicare Enrolled

Dr. Arina Golubeva-Ganeles, M.D.

Hematology & Oncology · Monterey, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
700 CASS ST. SUITE 128, Monterey, CA 93940
8319203222
In practice since 2006 (19 years)
NPI: 1790739191 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Golubeva-Ganeles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Golubeva-Ganeles? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Golubeva-Ganeles

Dr. Arina Golubeva-Ganeles is a hematology & oncology specialist in Monterey, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Golubeva-Ganeles performed 1,980 Medicare services across 648 unique beneficiaries.

Between the years covered by Open Payments, Dr. Golubeva-Ganeles received a total of $2,250 from 27 pharmaceutical and/or device companies across 78 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Golubeva-Ganeles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in CA $2,250 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,980
Medicare services
Top 40% in CA for hematology & oncology
648
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Principal care management for high-risk disease, first 30 minutes
This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month.
553 $67 $135
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
493 $100 $195
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
412 $148 $261
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $68 $133
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
117 $12 $39
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
117 $1 $45
Monthly chronic pain management bundle
A monthly service for chronic pain management that includes diagnosis, assessment, monitoring, and the development or revision of a person-centered care plan.
92 $66 $95
New patient office visit, complex (60-74 min) 32 $185 $337
Chronic care management services
Comprehensive assessment and care planning for patients requiring ongoing chronic care management.
23 $53 $70
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
16 $69 $130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,250
Total received (2018-2024)
Avg $321/year across 7 years
Bottom 46% in CA for hematology & oncology
27
Companies
78
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,441 (64.1%)
Other
Charitable contributions, space rental, and other categories
$781 (34.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$868
2023
$190
2022
$93
2021
$44
2020
$123
2019
$390
2018
$541

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$781
GlaxoSmithKline, LLC.
$36
Myriad Genetic Laboratories, Inc.
$31
Lilly USA, LLC
$20
Top 3 companies account for 97.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$875
E.R. Squibb & Sons, L.L.C.
$184
Foundation Medicine, Inc.
$130
Janssen Biotech, Inc.
$86
AstraZeneca Pharmaceuticals LP
$81
Lilly USA, LLC
$77
Puma Biotechnology, Inc.
$74
Myriad Genetic Laboratories, Inc.
$73
Amgen Inc.
$71
Seattle Genetics, Inc.
$66
AbbVie, Inc.
$62
Astellas Pharma US Inc
$54
Incyte Corporation
$51
Genentech USA, Inc.
$37
Endo Pharmaceuticals Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$36
GlaxoSmithKline, LLC.
$36
Stemline Therapeutics Inc.
$35
Merck Sharp & Dohme Corporation
$35
Mirati Therapeutics, Inc.
$27
Daiichi Sankyo Inc.
$23
Celgene Corporation
$21
TESARO, Inc.
$21
PFIZER INC.
$17
Exelixis Inc.
$17
Blueprint Medicines Corporation
$15
Gilead Sciences, Inc.
$12
Top 3 companies account for 52.9% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · ADCETRIS · AYVAKIT · Aliqopa · BRACAnalysis CDx · Cabometyx · DARZALEX · EMPLICITI · Enhertu · Erleada · FASLODEX · FOUNDATIONONE · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · NASCOBAL · NERLYNX · Nerlynx · Neulasta · Nubeqa · OPDIVO · Orserdu · PIQRAY · PRECISETUMOR · PROMACTA · REBLOZYL · TAGRISSO · VENCLEXTA · VERZENIO · Venclexta · XTANDI · ZEJULA · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Monterey?
Compare hematology & oncology specialists in the Monterey area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
12
Per 100K population
2.8
County median income
$94,486
Nearest hospital
COMMUNITY HOSPITAL OF THE MONTEREY PENINSULA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Golubeva-Ganeles is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Golubeva-Ganeles experienced with principal care management for high-risk disease, first 30 minutes?
Based on Medicare claims data, Dr. Golubeva-Ganeles performed 553 principal care management for high-risk disease, first 30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Golubeva-Ganeles receive payments from pharmaceutical companies?
Yes. Dr. Golubeva-Ganeles received a total of $2,250 from 27 companies across 78 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Golubeva-Ganeles's costs compare to other hematology & oncology specialists in Monterey?
Dr. Golubeva-Ganeles's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Golubeva-Ganeles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →